Stay updated on Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The update is a minor metadata revision (Revision: v3.4.1 added; Revision: v3.4.0 removed) with no changes to study data or page content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:09:50.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    24 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-15T04:59:33.000Z thumbnail image
  4. Check
    46 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing study sites in Georgia, Massachusetts, and New York (Atlanta/Emory, Boston/MGH, New York/NYU Perlmutter) and updated the record to revision v3.3.3. The HHS Vulnerability Disclosure footer link was removed.
    Difference
    0.4%
    Check dated 2025-12-23T21:40:34.000Z thumbnail image
  5. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added in the Study Documents section, replacing v3.2.0, with no substantive changes to the study details.
    Difference
    0.1%
    Check dated 2025-11-25T11:32:07.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    The funding-status notice about government operating status and related links has been removed from the page, removing an informational banner about potential delays. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:12:43.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    No significant changes detected in the study details page across the screenshots; the content and structure remain as before. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:11:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page.